These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23648435)

  • 41. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient involvement in the decision-making process improves satisfaction and quality of life in postmastectomy breast reconstruction.
    Ashraf AA; Colakoglu S; Nguyen JT; Anastasopulos AJ; Ibrahim AM; Yueh JH; Lin SJ; Tobias AM; Lee BT
    J Surg Res; 2013 Sep; 184(1):665-70. PubMed ID: 23706394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.
    Brewster AM; Parker PA
    Oncologist; 2011; 16(7):935-41. PubMed ID: 21672945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
    Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
    Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
    Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic mastectomy: who needs it, when and why.
    Burke EE; Portschy PR; Tuttle TM
    J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon?
    Soran A; Kamali Polat A; Johnson R; McGuire KP
    Surgeon; 2014 Dec; 12(6):316-22. PubMed ID: 24685410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
    Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
    J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy.
    Boughey JC; Hoskin TL; Hartmann LC; Johnson JL; Jacobson SR; Degnim AC; Frost MH
    Ann Surg Oncol; 2015 Feb; 22(2):401-8. PubMed ID: 25192678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.
    Portschy PR; Abbott AM; Burke EE; Nzara R; Marmor S; Kuntz KM; Tuttle TM
    Ann Surg Oncol; 2015 Nov; 22(12):3846-52. PubMed ID: 25762480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
    Güth U; Myrick ME; Viehl CT; Weber WP; Lardi AM; Schmid SM
    Eur J Surg Oncol; 2012 Apr; 38(4):296-301. PubMed ID: 22305274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine NE; Wallace J
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002748. PubMed ID: 21069671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A retrospective investigation of women's experience with breast reconstruction after mastectomy.
    Ditsch N; Bauerfeind I; Vodermaier A; Tripp C; Löhrs B; Toth B; Himsl I; Graeser M; Harbeck N; Lenhard M
    Arch Gynecol Obstet; 2013 Mar; 287(3):555-61. PubMed ID: 23090185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
    Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
    Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Body image, decision making, and breast cancer treatment.
    Kraus PL
    Cancer Nurs; 1999 Dec; 22(6):421-7; quiz 428-9. PubMed ID: 10603689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contralateral prophylactic mastectomy in breast cancer patients with a family history: a prospective 2-years follow-up study of health related quality of life, sexuality and body image.
    Unukovych D; Sandelin K; Liljegren A; Arver B; Wickman M; Johansson H; Brandberg Y
    Eur J Cancer; 2012 Nov; 48(17):3150-6. PubMed ID: 22695071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.
    Damle S; Teal CB; Lenert JJ; Marshall EC; Pan Q; McSwain AP
    Ann Surg Oncol; 2011 May; 18(5):1356-63. PubMed ID: 21125335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.